
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact
Gerasimos Evangelatos, G. Fragoulis, Vassiliki Koulouri, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 11, pp. 102391-102391
Closed Access | Times Cited: 177
Gerasimos Evangelatos, G. Fragoulis, Vassiliki Koulouri, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 11, pp. 102391-102391
Closed Access | Times Cited: 177
Showing 1-25 of 177 citing articles:
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Sarah Bajan, György Hutvàgner
Cells (2020) Vol. 9, Iss. 1, pp. 137-137
Open Access | Times Cited: 315
Sarah Bajan, György Hutvàgner
Cells (2020) Vol. 9, Iss. 1, pp. 137-137
Open Access | Times Cited: 315
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future
Jacopo Angelini, Rossella Talotta, Rossana Roncato, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1002-1002
Open Access | Times Cited: 148
Jacopo Angelini, Rossella Talotta, Rossana Roncato, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1002-1002
Open Access | Times Cited: 148
The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis
N. Petrovská, Klára Prajzlerová, Jiří Vencovský, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 5, pp. 102797-102797
Closed Access | Times Cited: 105
N. Petrovská, Klára Prajzlerová, Jiří Vencovský, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 5, pp. 102797-102797
Closed Access | Times Cited: 105
miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers
Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, et al.
Life Sciences (2022) Vol. 314, pp. 121321-121321
Closed Access | Times Cited: 71
Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, et al.
Life Sciences (2022) Vol. 314, pp. 121321-121321
Closed Access | Times Cited: 71
Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression
Liyan Lin, Keyi Zhang, Qiao Xiong, et al.
Journal of Autoimmunity (2023) Vol. 141, pp. 103001-103001
Open Access | Times Cited: 56
Liyan Lin, Keyi Zhang, Qiao Xiong, et al.
Journal of Autoimmunity (2023) Vol. 141, pp. 103001-103001
Open Access | Times Cited: 56
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Peng Jiao, Xingping Wang, Zhuoma Luoreng, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2308-2322
Open Access | Times Cited: 81
Peng Jiao, Xingping Wang, Zhuoma Luoreng, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2308-2322
Open Access | Times Cited: 81
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
Gerasimos Evangelatos, Giorgos Bamias, George D. Kitas, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1493-1511
Open Access | Times Cited: 62
Gerasimos Evangelatos, Giorgos Bamias, George D. Kitas, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1493-1511
Open Access | Times Cited: 62
Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
Clare C. Cunningham, S Wade, Achilleas Floudas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
Clare C. Cunningham, S Wade, Achilleas Floudas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis
Cen Chang, Lingxia Xu, Runrun Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Cen Chang, Lingxia Xu, Runrun Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
Tomasz Kmiołek, Agnieszka Paradowska‐Gorycka
Cells (2022) Vol. 11, Iss. 3, pp. 452-452
Open Access | Times Cited: 42
Tomasz Kmiołek, Agnieszka Paradowska‐Gorycka
Cells (2022) Vol. 11, Iss. 3, pp. 452-452
Open Access | Times Cited: 42
Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy
Diana Popescu, Elena Rezuş, Minerva Codruța Bădescu, et al.
Life (2023) Vol. 13, Iss. 2, pp. 319-319
Open Access | Times Cited: 23
Diana Popescu, Elena Rezuş, Minerva Codruța Bădescu, et al.
Life (2023) Vol. 13, Iss. 2, pp. 319-319
Open Access | Times Cited: 23
Exposome: Epigenetics and autoimmune diseases
Maria Giovanna Danieli, Marco Casciaro, Alberto Paladini, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103584-103584
Open Access | Times Cited: 10
Maria Giovanna Danieli, Marco Casciaro, Alberto Paladini, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103584-103584
Open Access | Times Cited: 10
Towards Personalized Medicine in Rheumatoid Arthritis
Seema Sharma, James Bluett
Open Access Rheumatology Research and Reviews (2024) Vol. Volume 16, pp. 89-114
Open Access | Times Cited: 8
Seema Sharma, James Bluett
Open Access Rheumatology Research and Reviews (2024) Vol. Volume 16, pp. 89-114
Open Access | Times Cited: 8
Genistein alleviates rheumatoid arthritis by inhibiting fibroblast-like synovial exosome secretion regulated by the Rab27/nSMase2/Mfge8 pathway
Jiajia Liu, Jinyang Shi, Shuling Niu, et al.
Food & Function (2025)
Open Access | Times Cited: 1
Jiajia Liu, Jinyang Shi, Shuling Niu, et al.
Food & Function (2025)
Open Access | Times Cited: 1
Chronic Immune Activation in TB/HIV Co-infection
Riti Sharan, Allison N. Bucşan, Shashank Ganatra, et al.
Trends in Microbiology (2020) Vol. 28, Iss. 8, pp. 619-632
Open Access | Times Cited: 54
Riti Sharan, Allison N. Bucşan, Shashank Ganatra, et al.
Trends in Microbiology (2020) Vol. 28, Iss. 8, pp. 619-632
Open Access | Times Cited: 54
Functional Interactions Between lncRNAs/circRNAs and miRNAs: Insights Into Rheumatoid Arthritis
Juanjuan Han, Xue‐Qiang Wang, Xinan Zhang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Juanjuan Han, Xue‐Qiang Wang, Xinan Zhang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soils
Wenjing Zhang, Yang Chen, Qin Liu, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 851-879
Closed Access | Times Cited: 33
Wenjing Zhang, Yang Chen, Qin Liu, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 851-879
Closed Access | Times Cited: 33
Exosomal microRNA-140-3p from human umbilical cord mesenchymal stem cells attenuates joint injury of rats with rheumatoid arthritis by silencing SGK1
Yijiang Huang, Liang Chen, Daosen Chen, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 32
Yijiang Huang, Liang Chen, Daosen Chen, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 32
Immunosenescence of T cells: a key player in rheumatoid arthritis
Yi Qin Gao, Weiwei Cai, Ying Zhou, et al.
Inflammation Research (2022) Vol. 71, Iss. 12, pp. 1449-1462
Closed Access | Times Cited: 30
Yi Qin Gao, Weiwei Cai, Ying Zhou, et al.
Inflammation Research (2022) Vol. 71, Iss. 12, pp. 1449-1462
Closed Access | Times Cited: 30
New Targets and Strategies for Rheumatoid Arthritis: From Signal Transduction to Epigenetic Aspect
Menglin Zhu, Qian Ding, Zhongxiao Lin, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 766-766
Open Access | Times Cited: 18
Menglin Zhu, Qian Ding, Zhongxiao Lin, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 766-766
Open Access | Times Cited: 18
Berberine encapsulated PEG-coated liposomes attenuate Wnt1/β-catenin signaling in rheumatoid arthritis via miR-23a activation
Sali Sujitha, Palani Dinesh, Mahaboobkhan Rasool
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 149, pp. 170-191
Closed Access | Times Cited: 45
Sali Sujitha, Palani Dinesh, Mahaboobkhan Rasool
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 149, pp. 170-191
Closed Access | Times Cited: 45
Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy
Rimsha Nooreen, Shweta Nene, Harsha Jain, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 397-419
Closed Access | Times Cited: 28
Rimsha Nooreen, Shweta Nene, Harsha Jain, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 397-419
Closed Access | Times Cited: 28
The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis
Jiujie Yang, Zhi Li, Linna Wang, et al.
Pharmacological Research (2022) Vol. 186, pp. 106549-106549
Open Access | Times Cited: 24
Jiujie Yang, Zhi Li, Linna Wang, et al.
Pharmacological Research (2022) Vol. 186, pp. 106549-106549
Open Access | Times Cited: 24
Role of miRNAs in Rheumatoid Arthritis Therapy
Yiping Zhang, Mei-wen Yang, Hongyan Xie, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1749-1749
Open Access | Times Cited: 14
Yiping Zhang, Mei-wen Yang, Hongyan Xie, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1749-1749
Open Access | Times Cited: 14
Fluorinated dendrimer-mediated miR-30a delivery regulates the inflammation of macrophages and mitigates the symptoms of rheumatoid arthritis
Jiakai Xing, Jiaxin Jia, Hugang Zhang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 1143-1159
Closed Access | Times Cited: 5
Jiakai Xing, Jiaxin Jia, Hugang Zhang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 1143-1159
Closed Access | Times Cited: 5